We are live on ! Find out more
CBU

CIBC Bancorp USA Portfolio holdings

AUM $82.3B
This Fund
S&P 500
This Quarter Est. Return
+20.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$82.3B
AUM Growth
+$7.86B
Cap. Flow
-$2.03B
Cap. Flow %
-2.47%
Top 10 Hldgs %
26.31%
Holding
2,056
New
305
Increased
737
Reduced
780
Closed
129

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$474M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$418M
3
AMZN icon
Amazon
AMZN
+$411M
4
MSFT icon
Microsoft
MSFT
+$358M
5
AAPL icon
Apple
AAPL
+$340M

Sector Composition

Rank Sector Weight
1 Technology 27.78%
2 Miscellaneous 15.13%
3 Financials 10.07%
4 Industrials 10.04%
5 Consumer Discretionary 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDT icon
1476
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.11B
$337K ﹤0.01%
+13,360
New +$337K
DFIC icon
1477
Dimensional International Core Equity 2 ETF
DFIC
$15.1B
$337K ﹤0.01%
9,050
– –
IBTG icon
1478
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$1.97B
$336K ﹤0.01%
14,700
– –
PAGP icon
1479
Plains GP Holdings
PAGP
$5.17B
$336K ﹤0.01%
13,852
+208
+2% +$4.99K
LTH icon
1480
Life Time Group Holdings
LTH
$8.96B
$335K ﹤0.01%
8,212
+493
+6% +$15.6K
ROAD icon
1481
Construction Partners
ROAD
$5.22B
$335K ﹤0.01%
2,822
+238
+9% +$28.2K
KBH icon
1482
KB Home
KBH
$2.88B
$335K ﹤0.01%
5,346
+531
+11% +$27.6K
IDN icon
1483
Intellicheck
IDN
$47.2M
$333K ﹤0.01%
81,289
+4,596
+6% +$27.6K
APGE
1484
DELISTED
Apogee Therapeutics
APGE
$331K ﹤0.01%
+2,495
New +$225K
CGON icon
1485
CG Oncology
CGON
$6.25B
$331K ﹤0.01%
4,074
+1,100
+37% +$71.9K
ESNT icon
1486
Essent Group
ESNT
$5.68B
$330K ﹤0.01%
5,134
-17
-0.3% -$1.03K
SXT icon
1487
Sensient Technologies
SXT
$5.48B
$330K ﹤0.01%
2,673
+157
+6% +$17.5K
CNR
1488
Core Natural Resources Inc
CNR
$4.29B
$330K ﹤0.01%
4,118
+260
+7% +$23K
JEPQ icon
1489
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$43.8B
$329K ﹤0.01%
5,360
+1,292
+32% +$76.7K
VSXY
1490
Victoria's Secret
VSXY
$7.12B
$329K ﹤0.01%
+3,941
New +$236K
IBP icon
1491
Installed Building Products
IBP
$5.15B
$328K ﹤0.01%
1,429
+123
+9% +$29.9K
PENN icon
1492
PENN Entertainment
PENN
$1.96B
$328K ﹤0.01%
+15,339
New +$275K
XENE icon
1493
Xenon Pharmaceuticals
XENE
$3.61B
$327K ﹤0.01%
5,423
+1,074
+25% +$59.6K
VCYT icon
1494
Veracyte
VCYT
$3.7B
$327K ﹤0.01%
+5,563
New +$233K
BCPC
1495
Balchem Corp
BCPC
$5.33B
$324K ﹤0.01%
1,918
+42
+2% +$6.98K
OGS icon
1496
ONE Gas
OGS
$4.54B
$323K ﹤0.01%
4,193
+341
+9% +$28.4K
SYNA icon
1497
Synaptics
SYNA
$4B
$323K ﹤0.01%
+2,598
New +$293K
CHYM
1498
Chime Financial
CHYM
$10B
$322K ﹤0.01%
15,708
-12,173
-44% -$236K
AVNT icon
1499
Avient
AVNT
$3.74B
$321K ﹤0.01%
8,682
+837
+11% +$30.3K
XLG icon
1500
Invesco S&P 500 Top 50 ETF
XLG
$11.7B
$321K ﹤0.01%
+5,237
New +$320K

Similar funds

CIBC Bancorp USA's Q2 2026 Portfolio in Review

As of Q2 2026, CIBC Bancorp USA held 2,056 positions worth $82.3B, up 11% from $74.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

CIBC Bancorp USA's Q2 2026 filing shows 305 new, 737 increased, 780 reduced and 129 closed positions. Its largest new stake was iShares MSCI Brazil ETF: 1,937,500 shares worth $66.8M. The largest sale was NVIDIA, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Financials.

  • CIBC Bancorp USA's largest Q2 2026 buy was iShares MSCI Brazil ETF: 1,937,500 shares worth $66.8M.
  • CIBC Bancorp USA added most to DraftKings in Q2 2026, an estimated $619M increase.
  • CIBC Bancorp USA's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $474M.
  • CIBC Bancorp USA fully exited Bio-Rad Laboratories Class A in Q2 2026, selling an estimated $33.5M.
  • CIBC Bancorp USA's ten largest holdings make up 26% of its $82.3B portfolio in Q2 2026.
  • CIBC Bancorp USA opened 305 new positions and closed 129 in Q2 2026.
  • CIBC Bancorp USA's portfolio value rose 11% quarter-over-quarter to $82.3B.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.